This scientific review presents a systematic exploration of the biochemical and molecular links between Acute Lymphoblastic Leukemia (ALL), bacterial infectious complications, and the body's protective metabolic mechanisms, with a dedicated focus on safeguarding the pediatric population. In the landscape of contemporary oncohematology, the efficacy of standard therapeutic protocols is widely documented; however, the resulting neutropenia and bone marrow replacement inevitably expose young patients to conditions of extreme immune vulnerability.
Through a rigorous analysis of clinical evidence extracted from international academic databases such as PubMed and ScienceDirect, this work sheds light on complex phenotypic dynamics—ranging from the phenomenon of diagnostic inversion (or ALL-like presentation) triggered by mycobacterial infections, to the systemic danger of fulminant streptococcal sepsis. This study does not merely map infectious criticalities; it introduces an integrated perspective by examining the immunomodulatory role of Vitamin D, the enzymatic stability provided by lysozyme and citrate, and the impact of nutritional biochemistry. Specifically, it analyzes how a diet free of palmitic acid can deprive pathogens of the lipid substrate necessary for their virulence. The objective of these pages is to provide a reference and clinical reflection tool to optimize the immunological support of children throughout their entire treatment journey.